AstraZeneca's latest TV ad for Farxiga and kidney disease shows people living with diabetes and hypertension as potential targets.

As­traZeneca ex­pands chron­ic kid­ney dis­ease 'Tar­get' cam­paign for Farx­i­ga

In its lat­est com­mer­cial for Farx­i­ga, As­traZeneca prompts peo­ple to ask their doc­tor for their kid­ney num­bers. But what does that mean? It’s a pa­tient-friend­ly way to de­scribe eGFR or uACR test­ing that helps de­ter­mine kid­ney func­tion, said Sarah Wal­ters, VP of car­dio­vas­cu­lar, re­nal and meta­bol­ic dis­eases at As­traZeneca.

She added, “We’re ty­ing to give them some lan­guage that opens up the di­a­logue with physi­cians.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.